Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
CLBT vs NTCT vs PANW vs AXON vs CSCO
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Aerospace & Defense
Communication Equipment
CLBT vs NTCT vs PANW vs AXON vs CSCO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Aerospace & Defense | Communication Equipment |
| Market Cap | $3.38B | $2.77B | $138.16B | $34.40B | $364.95B |
| Revenue (TTM) | $476M | $861M | $9.89B | $2.98B | $59.05B |
| Net Income (TTM) | $78M | $96M | $1.28B | $206M | $11.08B |
| Gross Margin | 84.2% | 79.2% | 73.5% | 59.3% | 64.4% |
| Operating Margin | 14.0% | 12.8% | 14.4% | 1.3% | 23.0% |
| Forward P/E | 37.5x | 15.9x | 53.3x | 55.0x | 22.2x |
| Total Debt | $23M | $76M | $338M | $1.91B | $29.64B |
| Cash & Equiv. | $124M | $457M | $2.27B | $1.20B | $9.47B |
CLBT vs NTCT vs PANW vs AXON vs CSCO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Cellebrite DI Ltd. (CLBT) | 100 | 138.7 | +38.7% |
| NetScout Systems, I… (NTCT) | 100 | 163.5 | +63.5% |
| Palo Alto Networks,… (PANW) | 100 | 401.2 | +301.2% |
| Axon Enterprise, In… (AXON) | 100 | 339.6 | +239.6% |
| Cisco Systems, Inc. (CSCO) | 100 | 214.2 | +114.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLBT vs NTCT vs PANW vs AXON vs CSCO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLBT ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 18.6%, EPS growth 123.0%, 3Y rev CAGR 20.7%
- Lower volatility, beta 0.76, Low D/E 4.7%, current ratio 1.56x
- Beta 0.76, current ratio 1.56x
- Beta 0.76 vs AXON's 1.19, lower leverage
NTCT is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (15.9x vs 22.2x)
- +80.5% vs AXON's -29.1%
Among these 5 stocks, PANW doesn't own a clear edge in any measured category.
AXON is the clearest fit if your priority is long-term compounding.
- 22.0% 10Y total return vs PANW's 7.5%
- 33.5% revenue growth vs NTCT's -0.8%
CSCO carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 15 yrs, beta 0.92, yield 1.7%
- 18.8% margin vs AXON's 6.9%
- 1.7% yield; 15-year raise streak; the other 4 pay no meaningful dividend
- 9.0% ROA vs AXON's 3.1%, ROIC 13.0% vs -1.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 33.5% revenue growth vs NTCT's -0.8% | |
| Value | Lower P/E (15.9x vs 22.2x) | |
| Quality / Margins | 18.8% margin vs AXON's 6.9% | |
| Stability / Safety | Beta 0.76 vs AXON's 1.19, lower leverage | |
| Dividends | 1.7% yield; 15-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +80.5% vs AXON's -29.1% | |
| Efficiency (ROA) | 9.0% ROA vs AXON's 3.1%, ROIC 13.0% vs -1.3% |
CLBT vs NTCT vs PANW vs AXON vs CSCO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CLBT vs NTCT vs PANW vs AXON vs CSCO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NTCT leads in 1 of 6 categories
CSCO leads 1 • CLBT leads 0 • PANW leads 0 • AXON leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AXON and CSCO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSCO is the larger business by revenue, generating $59.1B annually — 124.1x CLBT's $476M. CSCO is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to AXON's 6.9%. On growth, AXON holds the edge at +33.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $476M | $861M | $9.9B | $3.0B | $59.1B |
| EBITDAEarnings before interest/tax | $78M | $171M | $1.9B | $97M | $16.1B |
| Net IncomeAfter-tax profit | $78M | $96M | $1.3B | $206M | $11.1B |
| Free Cash FlowCash after capex | $160M | $275M | $4.1B | $20M | $12.8B |
| Gross MarginGross profit ÷ Revenue | +84.2% | +79.2% | +73.5% | +59.3% | +64.4% |
| Operating MarginEBIT ÷ Revenue | +14.0% | +12.8% | +14.4% | +1.3% | +23.0% |
| Net MarginNet income ÷ Revenue | +16.5% | +11.1% | +13.0% | +6.9% | +18.8% |
| FCF MarginFCF ÷ Revenue | +33.7% | +32.0% | +41.1% | +0.7% | +21.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.1% | -0.5% | +14.9% | +33.7% | +9.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +11.9% | +57.9% | +89.8% | +29.5% |
Valuation Metrics
NTCT leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 36.1x trailing earnings, CSCO trades at a 87% valuation discount to AXON's 282.7x P/E. On an enterprise value basis, CSCO's 26.3x EV/EBITDA is more attractive than AXON's 1664.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.4B | $2.8B | $138.2B | $34.4B | $365.0B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $2.4B | $136.2B | $35.1B | $385.1B |
| Trailing P/EPrice ÷ TTM EPS | 44.55x | -7.57x | 122.83x | 282.71x | 36.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.53x | 15.87x | 53.30x | 54.97x | 22.18x |
| PEG RatioP/E ÷ EPS growth rate | 0.76x | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 41.79x | — | 85.88x | 1664.88x | 26.34x |
| Price / SalesMarket cap ÷ Revenue | 7.10x | 3.36x | 14.98x | 12.37x | 6.44x |
| Price / BookPrice ÷ Book value/share | 7.13x | 1.78x | 17.82x | 13.16x | 7.87x |
| Price / FCFMarket cap ÷ FCF | 21.06x | 13.11x | 39.82x | 458.11x | 27.46x |
Profitability & Efficiency
Evenly matched — CLBT and PANW and CSCO each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CSCO delivers a 23.2% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $6 for NTCT. PANW carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSCO's 0.63x. On the Piotroski fundamental quality scale (0–9), CSCO scores 8/9 vs PANW's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.2% | +6.1% | +13.6% | +6.6% | +23.2% |
| ROA (TTM)Return on assets | +8.3% | +4.3% | +5.1% | +3.1% | +9.0% |
| ROICReturn on invested capital | +18.5% | -19.3% | +17.1% | -1.3% | +13.0% |
| ROCEReturn on capital employed | +13.8% | -18.5% | +8.9% | -1.5% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 4 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.05x | 0.05x | 0.04x | 0.59x | 0.63x |
| Net DebtTotal debt minus cash | -$102M | -$381M | -$1.9B | $709M | $20.2B |
| Cash & Equiv.Liquid assets | $124M | $457M | $2.3B | $1.2B | $9.5B |
| Total DebtShort + long-term debt | $23M | $76M | $338M | $1.9B | $29.6B |
| Interest CoverageEBIT ÷ Interest expense | — | 55.89x | 1559.00x | 1.18x | 9.64x |
Total Returns (Dividends Reinvested)
Evenly matched — CLBT and NTCT each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PANW five years ago would be worth $34,443 today (with dividends reinvested), compared to $13,992 for CLBT. Over the past 12 months, NTCT leads with a +80.5% total return vs AXON's -29.1%. The 3-year compound annual growth rate (CAGR) favors CLBT at 36.3% vs NTCT's 9.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -22.6% | +42.6% | +9.6% | -24.2% | +22.3% |
| 1-Year ReturnPast 12 months | -27.6% | +80.5% | +4.5% | -29.1% | +57.5% |
| 3-Year ReturnCumulative with dividends | +153.4% | +30.3% | +105.2% | +92.4% | +109.3% |
| 5-Year ReturnCumulative with dividends | +39.9% | +42.9% | +244.4% | +216.8% | +87.2% |
| 10-Year ReturnCumulative with dividends | +43.0% | +66.6% | +746.7% | +2200.0% | +301.7% |
| CAGR (3Y)Annualised 3-year return | +36.3% | +9.2% | +27.1% | +24.4% | +27.9% |
Risk & Volatility
Evenly matched — CLBT and NTCT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CLBT is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than AXON's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTCT currently trades 97.6% from its 52-week high vs AXON's 48.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.12x | 1.02x | 1.19x | 0.92x |
| 52-Week HighHighest price in past year | $20.45 | $39.24 | $223.61 | $885.92 | $94.72 |
| 52-Week LowLowest price in past year | $11.02 | $19.98 | $139.57 | $339.01 | $59.07 |
| % of 52W HighCurrent price vs 52-week peak | +67.5% | +97.6% | +87.9% | +48.2% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 68.6 | 61.6 | 40.5 | 63.9 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 552K | 7.5M | 1.0M | 18.9M |
Analyst Outlook
CSCO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CLBT as "Buy", NTCT as "Hold", PANW as "Buy", AXON as "Buy", CSCO as "Buy". Consensus price targets imply 70.2% upside for AXON (target: $727) vs -24.3% for NTCT (target: $29). CSCO is the only dividend payer here at 1.75% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $20.67 | $29.00 | $207.85 | $726.71 | $96.50 |
| # AnalystsCovering analysts | 8 | 21 | 86 | 21 | 73 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +1.7% |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | 15 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.61 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% | 0.0% | 0.0% | +2.0% |
NTCT leads in 1 of 6 categories (Valuation Metrics). CSCO leads in 1 (Analyst Outlook). 4 tied.
CLBT vs NTCT vs PANW vs AXON vs CSCO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLBT or NTCT or PANW or AXON or CSCO a better buy right now?
For growth investors, Axon Enterprise, Inc.
(AXON) is the stronger pick with 33. 5% revenue growth year-over-year, versus -0. 8% for NetScout Systems, Inc. (NTCT). Cisco Systems, Inc. (CSCO) offers the better valuation at 36. 1x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Cellebrite DI Ltd. (CLBT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLBT or NTCT or PANW or AXON or CSCO?
On trailing P/E, Cisco Systems, Inc.
(CSCO) is the cheapest at 36. 1x versus Axon Enterprise, Inc. at 282. 7x. On forward P/E, NetScout Systems, Inc. is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CLBT or NTCT or PANW or AXON or CSCO?
Over the past 5 years, Palo Alto Networks, Inc.
(PANW) delivered a total return of +244. 4%, compared to +39. 9% for Cellebrite DI Ltd. (CLBT). Over 10 years, the gap is even starker: AXON returned +22. 0% versus CLBT's +43. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLBT or NTCT or PANW or AXON or CSCO?
By beta (market sensitivity over 5 years), Cellebrite DI Ltd.
(CLBT) is the lower-risk stock at 0. 76β versus Axon Enterprise, Inc. 's 1. 19β — meaning AXON is approximately 57% more volatile than CLBT relative to the S&P 500. On balance sheet safety, Palo Alto Networks, Inc. (PANW) carries a lower debt/equity ratio of 4% versus 63% for Cisco Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLBT or NTCT or PANW or AXON or CSCO?
By revenue growth (latest reported year), Axon Enterprise, Inc.
(AXON) is pulling ahead at 33. 5% versus -0. 8% for NetScout Systems, Inc. (NTCT). On earnings-per-share growth, the picture is similar: Cellebrite DI Ltd. grew EPS 123. 0% year-over-year, compared to -144. 4% for NetScout Systems, Inc.. Over a 3-year CAGR, AXON leads at 32. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLBT or NTCT or PANW or AXON or CSCO?
Cisco Systems, Inc.
(CSCO) is the more profitable company, earning 18. 0% net margin versus -44. 6% for NetScout Systems, Inc. — meaning it keeps 18. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSCO leads at 20. 8% versus -44. 7% for NTCT. At the gross margin level — before operating expenses — CLBT leads at 84. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLBT or NTCT or PANW or AXON or CSCO more undervalued right now?
On forward earnings alone, NetScout Systems, Inc.
(NTCT) trades at 15. 9x forward P/E versus 55. 0x for Axon Enterprise, Inc. — 39. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AXON: 70. 2% to $726. 71.
08Which pays a better dividend — CLBT or NTCT or PANW or AXON or CSCO?
In this comparison, CSCO (1.
7% yield) pays a dividend. CLBT, NTCT, PANW, AXON do not pay a meaningful dividend and should not be held primarily for income.
09Is CLBT or NTCT or PANW or AXON or CSCO better for a retirement portfolio?
For long-horizon retirement investors, Cisco Systems, Inc.
(CSCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 1. 7% yield, +301. 7% 10Y return). Both have compounded well over 10 years (CSCO: +301. 7%, AXON: +22. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLBT and NTCT and PANW and AXON and CSCO?
These companies operate in different sectors (CLBT (Technology) and NTCT (Technology) and PANW (Technology) and AXON (Industrials) and CSCO (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CLBT is a small-cap high-growth stock; NTCT is a small-cap quality compounder stock; PANW is a mid-cap quality compounder stock; AXON is a mid-cap high-growth stock; CSCO is a large-cap quality compounder stock. CSCO pays a dividend while CLBT, NTCT, PANW, AXON do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.